NuVision follows its vision with £500,000 investment

NuVision follows its vision with £500,000 investment

NuVision Biotherapies is delighted to announce the recent completion of a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham. The investment will enable the company to increase sales both in the UK and to develop...
NuVision is Recruiting a Sales Team

NuVision is Recruiting a Sales Team

We are currently inviting applications for opportunities with the Commercial Specialist Team. We have opportunities on the following territories: Southern England London and East Anglia Midlands North England About NuVision Biotherapies This is your chance to join one...
NuVision step into Europe

NuVision step into Europe

NuVision Biotherapies Limited, a UK-based regenerative medicine company, and University of Tampere, Regea Cell and Tissue Centre, a Finnish clinical tissue bank, have announced the signing of a strategic partnership to distribute the sight saving and wound care...
NuVision – ECVO Congress 2017

NuVision – ECVO Congress 2017

The European Society of Veterinary Ophthalmology (ECVO) meeting in Estoril, Portugal took place last week with 3 of our team attending. NuVision CEO, Dr Andrew Hopkinson presented on ‘Acute Treatment of Inflammatory Disease or Injuries’ which was very well received....
Success for NuVision at Pitch@Palace, Birmingham

Success for NuVision at Pitch@Palace, Birmingham

This week, NuVision Biotherapies attended ‘Pitch@Palace’ on tour at KPMG in Birmingham. Pitch@Palace is an initiative set up by HRH Prince Andrew, Duke of York, in order to provide entrepreneurs with guidance and help as well as connecting them with...